"Biovest retains Ferghana Partners to evaluate strategic transactions (BVTI) 0.39 -0.01 : Co announced that Biovest has retained Ferghana Partners as the Company's strategic transaction advisor to evaluate/implement creative financings and partnering opportunities on a regional or global basis for BiovaxID, its late-stage personalized cancer vaccine for the treatment of non-Hodgkin's lymphoma. "
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.